ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Radionuclide Therapy Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-6R15810
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Radionuclide Therapy Market Research Report 2023
BUY CHAPTERS

Global Targeted Radionuclide Therapy Market Research Report 2025

Code: QYRE-Auto-6R15810
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals

Targeted Radionuclide Therapy Market Size

The global market for Targeted Radionuclide Therapy was valued at US$ 1975 million in the year 2024 and is projected to reach a revised size of US$ 5982 million by 2031, growing at a CAGR of 17.4% during the forecast period.

Targeted Radionuclide Therapy Market

Targeted Radionuclide Therapy Market

Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.
This report aims to provide a comprehensive presentation of the global market for Targeted Radionuclide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Radionuclide Therapy.
The Targeted Radionuclide Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Radionuclide Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Radionuclide Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Radionuclide Therapy Market Report

Report Metric Details
Report Name Targeted Radionuclide Therapy Market
Accounted market size in year US$ 1975 million
Forecasted market size in 2031 US$ 5982 million
CAGR 17.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Beta-emitting
  • Targeted Alpha Therapy
Segment by Application
  • Solid Tumor
  • Non Hodgkin Lymphoma
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Radionuclide Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Radionuclide Therapy Market growing?

Ans: The Targeted Radionuclide Therapy Market witnessing a CAGR of 17.4% during the forecast period 2025-2031.

What is the Targeted Radionuclide Therapy Market size in 2031?

Ans: The Targeted Radionuclide Therapy Market size in 2031 will be US$ 5982 million.

Who are the main players in the Targeted Radionuclide Therapy Market report?

Ans: The main players in the Targeted Radionuclide Therapy Market are Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals

What are the Application segmentation covered in the Targeted Radionuclide Therapy Market report?

Ans: The Applications covered in the Targeted Radionuclide Therapy Market report are Solid Tumor, Non Hodgkin Lymphoma

What are the Type segmentation covered in the Targeted Radionuclide Therapy Market report?

Ans: The Types covered in the Targeted Radionuclide Therapy Market report are Beta-emitting, Targeted Alpha Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radionuclide Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Beta-emitting
1.2.3 Targeted Alpha Therapy
1.3 Market by Application
1.3.1 Global Targeted Radionuclide Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Solid Tumor
1.3.3 Non Hodgkin Lymphoma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radionuclide Therapy Market Perspective (2020-2031)
2.2 Global Targeted Radionuclide Therapy Growth Trends by Region
2.2.1 Global Targeted Radionuclide Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Radionuclide Therapy Historic Market Size by Region (2020-2025)
2.2.3 Targeted Radionuclide Therapy Forecasted Market Size by Region (2026-2031)
2.3 Targeted Radionuclide Therapy Market Dynamics
2.3.1 Targeted Radionuclide Therapy Industry Trends
2.3.2 Targeted Radionuclide Therapy Market Drivers
2.3.3 Targeted Radionuclide Therapy Market Challenges
2.3.4 Targeted Radionuclide Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Radionuclide Therapy Players by Revenue
3.1.1 Global Top Targeted Radionuclide Therapy Players by Revenue (2020-2025)
3.1.2 Global Targeted Radionuclide Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Radionuclide Therapy Revenue
3.4 Global Targeted Radionuclide Therapy Market Concentration Ratio
3.4.1 Global Targeted Radionuclide Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Therapy Revenue in 2024
3.5 Global Key Players of Targeted Radionuclide Therapy Head office and Area Served
3.6 Global Key Players of Targeted Radionuclide Therapy, Product and Application
3.7 Global Key Players of Targeted Radionuclide Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radionuclide Therapy Breakdown Data by Type
4.1 Global Targeted Radionuclide Therapy Historic Market Size by Type (2020-2025)
4.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2026-2031)
5 Targeted Radionuclide Therapy Breakdown Data by Application
5.1 Global Targeted Radionuclide Therapy Historic Market Size by Application (2020-2025)
5.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Radionuclide Therapy Market Size (2020-2031)
6.2 North America Targeted Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Radionuclide Therapy Market Size by Country (2020-2025)
6.4 North America Targeted Radionuclide Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Radionuclide Therapy Market Size (2020-2031)
7.2 Europe Targeted Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Radionuclide Therapy Market Size by Country (2020-2025)
7.4 Europe Targeted Radionuclide Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radionuclide Therapy Market Size (2020-2031)
8.2 Asia-Pacific Targeted Radionuclide Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Radionuclide Therapy Market Size (2020-2031)
9.2 Latin America Targeted Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Radionuclide Therapy Market Size by Country (2020-2025)
9.4 Latin America Targeted Radionuclide Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radionuclide Therapy Market Size (2020-2031)
10.2 Middle East & Africa Targeted Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Radionuclide Therapy Introduction
11.1.4 Bayer Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Targeted Radionuclide Therapy Introduction
11.2.4 Novartis Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Lantheus
11.3.1 Lantheus Company Details
11.3.2 Lantheus Business Overview
11.3.3 Lantheus Targeted Radionuclide Therapy Introduction
11.3.4 Lantheus Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.3.5 Lantheus Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Details
11.4.2 Aurobindo Pharma Business Overview
11.4.3 Aurobindo Pharma Targeted Radionuclide Therapy Introduction
11.4.4 Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.4.5 Aurobindo Pharma Recent Development
11.5 Mundipharma
11.5.1 Mundipharma Company Details
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Targeted Radionuclide Therapy Introduction
11.5.4 Mundipharma Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.5.5 Mundipharma Recent Development
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Details
11.6.2 China Isotope & Radiation Business Overview
11.6.3 China Isotope & Radiation Targeted Radionuclide Therapy Introduction
11.6.4 China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.6.5 China Isotope & Radiation Recent Development
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Details
11.7.2 Curium Pharmaceuticals Business Overview
11.7.3 Curium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.7.4 Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.7.5 Curium Pharmaceuticals Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Targeted Radionuclide Therapy Introduction
11.8.4 Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.8.5 Gilead Sciences Recent Development
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Details
11.9.2 Clarity Pharmaceuticals Business Overview
11.9.3 Clarity Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.9.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.9.5 Clarity Pharmaceuticals Recent Development
11.10 Curasight
11.10.1 Curasight Company Details
11.10.2 Curasight Business Overview
11.10.3 Curasight Targeted Radionuclide Therapy Introduction
11.10.4 Curasight Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.10.5 Curasight Recent Development
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Details
11.11.2 Nordic Nanovector Business Overview
11.11.3 Nordic Nanovector Targeted Radionuclide Therapy Introduction
11.11.4 Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.11.5 Nordic Nanovector Recent Development
11.12 Philogen
11.12.1 Philogen Company Details
11.12.2 Philogen Business Overview
11.12.3 Philogen Targeted Radionuclide Therapy Introduction
11.12.4 Philogen Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.12.5 Philogen Recent Development
11.13 RadioMedix
11.13.1 RadioMedix Company Details
11.13.2 RadioMedix Business Overview
11.13.3 RadioMedix Targeted Radionuclide Therapy Introduction
11.13.4 RadioMedix Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.13.5 RadioMedix Recent Development
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Details
11.14.2 Telix Pharmaceuticals Business Overview
11.14.3 Telix Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.14.4 Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.14.5 Telix Pharmaceuticals Recent Development
11.15 Orano Med
11.15.1 Orano Med Company Details
11.15.2 Orano Med Business Overview
11.15.3 Orano Med Targeted Radionuclide Therapy Introduction
11.15.4 Orano Med Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.15.5 Orano Med Recent Development
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Details
11.16.2 Actinium Pharmaceuticals Business Overview
11.16.3 Actinium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.16.4 Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.16.5 Actinium Pharmaceuticals Recent Development
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Details
11.17.2 Y-mAbs Therapeutics Business Overview
11.17.3 Y-mAbs Therapeutics Targeted Radionuclide Therapy Introduction
11.17.4 Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.17.5 Y-mAbs Therapeutics Recent Development
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Details
11.18.2 Fusion Pharmaceuticals Business Overview
11.18.3 Fusion Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.18.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025)
11.18.5 Fusion Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
List of Tables
 Table 1. Global Targeted Radionuclide Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Beta-emitting
 Table 3. Key Players of Targeted Alpha Therapy
 Table 4. Global Targeted Radionuclide Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Targeted Radionuclide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Targeted Radionuclide Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Targeted Radionuclide Therapy Market Share by Region (2020-2025)
 Table 8. Global Targeted Radionuclide Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Targeted Radionuclide Therapy Market Share by Region (2026-2031)
 Table 10. Targeted Radionuclide Therapy Market Trends
 Table 11. Targeted Radionuclide Therapy Market Drivers
 Table 12. Targeted Radionuclide Therapy Market Challenges
 Table 13. Targeted Radionuclide Therapy Market Restraints
 Table 14. Global Targeted Radionuclide Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Targeted Radionuclide Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2024)
 Table 17. Ranking of Global Top Targeted Radionuclide Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Targeted Radionuclide Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Targeted Radionuclide Therapy, Product and Application
 Table 21. Global Key Players of Targeted Radionuclide Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Targeted Radionuclide Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Targeted Radionuclide Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Targeted Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Targeted Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Targeted Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Targeted Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Targeted Radionuclide Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Targeted Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Targeted Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bayer Company Details
 Table 47. Bayer Business Overview
 Table 48. Bayer Targeted Radionuclide Therapy Product
 Table 49. Bayer Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 50. Bayer Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis Targeted Radionuclide Therapy Product
 Table 54. Novartis Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 55. Novartis Recent Development
 Table 56. Lantheus Company Details
 Table 57. Lantheus Business Overview
 Table 58. Lantheus Targeted Radionuclide Therapy Product
 Table 59. Lantheus Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 60. Lantheus Recent Development
 Table 61. Aurobindo Pharma Company Details
 Table 62. Aurobindo Pharma Business Overview
 Table 63. Aurobindo Pharma Targeted Radionuclide Therapy Product
 Table 64. Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 65. Aurobindo Pharma Recent Development
 Table 66. Mundipharma Company Details
 Table 67. Mundipharma Business Overview
 Table 68. Mundipharma Targeted Radionuclide Therapy Product
 Table 69. Mundipharma Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 70. Mundipharma Recent Development
 Table 71. China Isotope & Radiation Company Details
 Table 72. China Isotope & Radiation Business Overview
 Table 73. China Isotope & Radiation Targeted Radionuclide Therapy Product
 Table 74. China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 75. China Isotope & Radiation Recent Development
 Table 76. Curium Pharmaceuticals Company Details
 Table 77. Curium Pharmaceuticals Business Overview
 Table 78. Curium Pharmaceuticals Targeted Radionuclide Therapy Product
 Table 79. Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 80. Curium Pharmaceuticals Recent Development
 Table 81. Gilead Sciences Company Details
 Table 82. Gilead Sciences Business Overview
 Table 83. Gilead Sciences Targeted Radionuclide Therapy Product
 Table 84. Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 85. Gilead Sciences Recent Development
 Table 86. Clarity Pharmaceuticals Company Details
 Table 87. Clarity Pharmaceuticals Business Overview
 Table 88. Clarity Pharmaceuticals Targeted Radionuclide Therapy Product
 Table 89. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 90. Clarity Pharmaceuticals Recent Development
 Table 91. Curasight Company Details
 Table 92. Curasight Business Overview
 Table 93. Curasight Targeted Radionuclide Therapy Product
 Table 94. Curasight Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 95. Curasight Recent Development
 Table 96. Nordic Nanovector Company Details
 Table 97. Nordic Nanovector Business Overview
 Table 98. Nordic Nanovector Targeted Radionuclide Therapy Product
 Table 99. Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 100. Nordic Nanovector Recent Development
 Table 101. Philogen Company Details
 Table 102. Philogen Business Overview
 Table 103. Philogen Targeted Radionuclide Therapy Product
 Table 104. Philogen Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 105. Philogen Recent Development
 Table 106. RadioMedix Company Details
 Table 107. RadioMedix Business Overview
 Table 108. RadioMedix Targeted Radionuclide Therapy Product
 Table 109. RadioMedix Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 110. RadioMedix Recent Development
 Table 111. Telix Pharmaceuticals Company Details
 Table 112. Telix Pharmaceuticals Business Overview
 Table 113. Telix Pharmaceuticals Targeted Radionuclide Therapy Product
 Table 114. Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 115. Telix Pharmaceuticals Recent Development
 Table 116. Orano Med Company Details
 Table 117. Orano Med Business Overview
 Table 118. Orano Med Targeted Radionuclide Therapy Product
 Table 119. Orano Med Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 120. Orano Med Recent Development
 Table 121. Actinium Pharmaceuticals Company Details
 Table 122. Actinium Pharmaceuticals Business Overview
 Table 123. Actinium Pharmaceuticals Targeted Radionuclide Therapy Product
 Table 124. Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 125. Actinium Pharmaceuticals Recent Development
 Table 126. Y-mAbs Therapeutics Company Details
 Table 127. Y-mAbs Therapeutics Business Overview
 Table 128. Y-mAbs Therapeutics Targeted Radionuclide Therapy Product
 Table 129. Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 130. Y-mAbs Therapeutics Recent Development
 Table 131. Fusion Pharmaceuticals Company Details
 Table 132. Fusion Pharmaceuticals Business Overview
 Table 133. Fusion Pharmaceuticals Targeted Radionuclide Therapy Product
 Table 134. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2020-2025) & (US$ Million)
 Table 135. Fusion Pharmaceuticals Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Targeted Radionuclide Therapy Picture
 Figure 2. Global Targeted Radionuclide Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Radionuclide Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Beta-emitting Features
 Figure 5. Targeted Alpha Therapy Features
 Figure 6. Global Targeted Radionuclide Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Targeted Radionuclide Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Solid Tumor Case Studies
 Figure 9. Non Hodgkin Lymphoma Case Studies
 Figure 10. Targeted Radionuclide Therapy Report Years Considered
 Figure 11. Global Targeted Radionuclide Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Targeted Radionuclide Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Targeted Radionuclide Therapy Market Share by Region: 2024 VS 2031
 Figure 14. Global Targeted Radionuclide Therapy Market Share by Players in 2024
 Figure 15. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Targeted Radionuclide Therapy Revenue in 2024
 Figure 17. North America Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Targeted Radionuclide Therapy Market Share by Country (2020-2031)
 Figure 19. United States Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Targeted Radionuclide Therapy Market Share by Country (2020-2031)
 Figure 23. Germany Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Targeted Radionuclide Therapy Market Share by Region (2020-2031)
 Figure 31. China Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Targeted Radionuclide Therapy Market Share by Country (2020-2031)
 Figure 39. Mexico Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Targeted Radionuclide Therapy Market Share by Country (2020-2031)
 Figure 43. Turkey Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Targeted Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Bayer Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 47. Novartis Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 48. Lantheus Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 49. Aurobindo Pharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 50. Mundipharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 51. China Isotope & Radiation Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 52. Curium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 53. Gilead Sciences Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 54. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 55. Curasight Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 56. Nordic Nanovector Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 57. Philogen Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 58. RadioMedix Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 59. Telix Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 60. Orano Med Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 61. Actinium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 62. Y-mAbs Therapeutics Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 63. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Therapeutic Radioligands Market Research Report 2024
Global Targeted Radiotherapy Drug Market Research Report 2024
Global Antibody radionuclide Conjugates Market Research Report 2024
Global Targeted Radiopharmaceuticals Market Research Report 2024
Global Radioactive Therapeutic Drugs Market Research Report 2024
Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Drug for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030
Global Medical Alpha Radionuclide Market Research Report 2024
Global Targeted Alpha particle Therapy Market Research Report 2024
Global Radioimmunotherapy Market Research Report 2025
Global Systemic Radiotherapy Market Research Report 2024
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Drug Market Research Report 2025
Global Cancer Targeted Drug Market Research Report 2025
Global Oncology Targeted Therapy Market Research Report 2025
Global Radioligand Therapy Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions